MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks
You are here: Home / Business/Financial News / MassDevice Earnings Roundup / Zimmer slides on Q1 results | Earnings Roundup

Zimmer slides on Q1 results | Earnings Roundup

April 26, 2012 By MassDevice staff Leave a Comment

MassDevice.com Earnings Roundup

Investors sent shares of Zimmer (NYSE:ZMH) down 5% this morning in pre-market trading after the orthopedic device maker reported sales and earnings in-line with Wall Street’s expectations, but lackluster sales of hip and knee implants.

The Warsaw, Ind.-based company posted profits of $209.6 million, or $1.17 per diluted share, on sales of $1.14 billion for the 3 months ended March 31.

That’s a bottom-line gain of less than 1% and a top-line addition of 2.2%, compared with profits of $208.9 million, or $1.08 diluted EPS, on sales of $1.12 billion during Q1 2011. Diluted EPS rose 8.3% year-over-year.

"Zimmer delivered year-over-year sales growth in all geographic segments and in most product categories in the quarter," president & CEO David Dvorak said in prepared remarks. "Looking forward, our new product introductions and progress in our transformation programs will enable the Company to generate increased value to stockholders."

Overall sales of joint reconstruction products rose 2% to $860 million, with most of that growth coming from the Asia-Pacific region. U.S. recon sales growth was flat, as were the revenue figures for domestic sales of knee and hip implants, at $468 million, $279 million and $154 million, respectively.

"We think some may be a bit disappointed that US hip/knee growth did not show as much of a sequential y/y growth acceleration this quarter as some may have been expecting, especially in knees,” wrote Leerink Swann analyst Richard Newitter in a note to investors this morning. “This reinforces our view that US ortho recon markets have likely bottomed and remain stable, possibly even beginning to show some early signs of improvement. However, we still think it’s too early to call an inflection point for a procedure volume recovery.”

Zimmer lowered its 2012 sales guidance to growth of between 0% and 2.5%, saying it expects foreign exchange rates to cut the top line by between 1.5% and 2%. Its prior guidance predicted FX to cut about 1% from revenues.

Diluted EPS are forecast to run between $4.70 and $4.90, down from $4.75 to $4.95.

ZMH shares opened today at $61.20, down 3.5% from yesterday’s $63.43 close. Shares were trading up slightly at $61.35 as of about 9:45 this morning.

 Second-quarter profits slide 24% for Hill-Rom
Hill-Rom Holdings (NYSE:HRC) posted profits of $25.3 million, or 40¢ per diluted share, on sales of $415.1 million for the 3 months ended March 31.

That compares with profits of $33.1 million, or 52¢ per diluted share, on sales of $402.1 million during the same period last year.
Read more

 Merit Medical’s Q1 profits slide despite sales increase
Merit Medical (NSDQ:MMSI) posted profits of $5.7 million, or 14¢ per diluted share, on sales of $95.6 million for the 3 months ended March 31.

That compares with profits of $6.6 million, or 18¢ per diluted share, on sales of $86.6 million during the same period last year.
Read more

 Sales plunge, losses tick up for NeuroMetrix during Q1
NeuroMetrix (NSDQ:NURO) posted losses of $2.8 million, or 33¢ per share, on sales of $2.1 million for the 3 months ended March 31.

That compares with losses of $2.7 million, or 70¢ per share, on sales of $2.9 million during the same period last year.
Read more

 Palomar’s Q1 losses soar 21% on slow sales growth
Palomar Medical (NSDQ:PMTI) posted losses of $2.3 million, or 12¢ per share, on sales of $19.0 million for the 3 months ended March 31.

That compares with losses of $1.9 million, or 10¢ per share, on sales of $18.2 million during the same period last year.
Read more

 Shire’s DermaGraft sales stay flat
British biotech Shire (NSDQ:SHPGY) said it sold $48.8 million worth of the Dermagraft skin substitute during the 1st quarter. Since Q3 2011, Shire’s reeled in about $143.4 million from the regenerative medicine product ($50 million in Q3 2011, $55 million in Q4 and the $48.8 million logged in Q1 2012).

Overall, Shire posted profits of $238.4 million, or 41¢ per diluted share, on sales of $1.17 billion for the 3 months ended March 31.

That compares with profits of $211.3 million, or 37¢ per diluted share, on sales of $972.2 million during the same period last year.
Read more

 Sorin’s Q1 profits slide
Sorin Group (BIT:SRN) posted profits of $15 million (€191.7M) on sales of $272 million (€191.7M) for the 3 months ended March 31.

That compares with profits of $18 million (€10.6M) on sales of $259 million (€182.3M) during the same period last year.
Read more

 Varian Medical’s Q2 sales, earnings rise
Varian Medical (NYSE:VAR) posted profits of $107.8 million, or 94¢ per diluted share, on sales of $720.3 million for the 3 months ended March 31.

That compares with profits of $103.1 million, or 86¢ per diluted share, on sales of $648.4 million during the same period last year.
Read more

More medical device sales and earnings from MassDevice.com

  • Sales up 4% last year for Arrhythmia Research Technology
  • ConMed posts double-digit Q1 profit growth
  • EnteroMedics logs first revenues in Q1
  • Sales soar, profits plunge for Grifols in 2011
  • FDA woes cut 22% from Invacare’s Q1 bottom line
  • Kelyniam sports record Q1 cranial implant sales
  • Sales up, earnings down for Natus Medical
  • NeoVasc adds 21% to top line
  • Rochester Medical swings to Q2 black
  • So does Spectranetics
  • Q1 sales, earnings up for RTI Biologics
  • Utah Medical’s Q1 sales soar, earnings skyrocket
  • Vascular Solutions bests sales Q1 guidance
  • Sales, income rise for Young Innovations

Filed Under: MassDevice Earnings Roundup, News Well, Orthopedics Tagged With: 2012, Arrhythmia Research Technology Inc., ConMed Corp., EnteroMedics Inc., Grifols, Hillrom, Hips, Invacare, Kelyniam Global Inc., Knees, Merit Medical Systems, Natus Medical Inc., neovasc, Neurometrix, Palomar Medical Technologies Inc., Q1, Rochester Medical Corp., RTI Surgical, Shire Plc., Sorin Group, Spectranetics Corp., Utah Medical, Varian Medical Systems, vascularsolutions, Young Innovations, Zimmer Biomet

In case you missed it

  • Bio-Rad recovering from ransomware attack
  • FDA clears first single-use duodenoscope from Boston Sci
  • FDA approves Tandem Diabetes’ advanced hybrid closed-loop controller
  • Awak Technologies raises $40m
  • Axonics raises additional $17m in public offering
  • Siemens Healthineers lands FDA clearance for two CT systems
  • Aethlon prices $5m offering
  • Sterigenics’ legal troubles mount in Illinois
  • In2Bones launches AlloAid BioNail
  • Caresyntax to acquire Syus; raises $45.6m
  • Nihon Kohden launches new patient monitor
  • Senate confirms Dr. Stephen Hahn to lead FDA
  • Iradimed renews CE mark for MRI-safe patient monitor
  • Flexicare recalls fiber optic laryngoscope blades and handles
  • 3M to sell drug-delivery biz to Altaris Capital Partners for $650m
  • TransEnterix announces reverse split of common stock
  • GI Windows raises $15m Series A

RSS From Medical Design & Outsourcing

  • Siemens Healthineers lands FDA clearance for two CT systems
    Siemens Healthineers this week said it won FDA clearance for its Somatom go.Sim and Somtom go.Open Pro computed tomography systems. The CT systems are designed for radiation therapy planning and are members of the company’s Somatom go. platform of devices. Siemens Healthineers’ platform uses hardware and software components like patient marking lasers and automated quality… […]
  • Protolabs’ healthcare grant spurs 2 feeding tube inventions
    Digital manufacturer Protolabs (NYSE:PRLB) announced today that MedStar Health (Columbia, Md.) and Cleveland Clinic Innovations are joint winners of the company’s Cool Idea Award: Healthcare Grant. These grants provide in-kind manufacturing services to the support development of medical products to spur innovation in the field. MedStar Health’s gravity-feed syringe holder simplifies the feeding of newborns who spend […]
  • Sterigenics’ legal troubles mount in Illinois
    Nearly two dozen new lawsuits were filed against Sterigenics this week over its now-shuttered ethylene oxide (EtO) sterilization plant in Willowbrook, Ill., according to a law firm representing some of the plaintiffs. That brings the total of such lawsuits to nearly 75, noted Chicago personal injury lawyer Antonio Romanucci, court-appointed lead counsel from among five… […]
  • In2Bones launches AlloAid BioNail
    In2Bones this week launched its AlloAid BioNail sterile allograft implant. The implant is designed to give rigid, stable fixation during hand and foot reconstruction. AlloAid BioNail is made from strong cortical allografts to provide osteoconductive properties for bone remodeling and healing. It features a tapered point and multiple, contoured wedge facets to ease insertion, anchor… […]
  • Protolabs’ healthcare grant spurs 2 feeding tube inventions
    Digital manufacturer Protolabs (NYSE:PRLB) announced today that MedStar Health (Columbia, Md.) and Cleveland Clinic Innovations are joint winners of the company’s Cool Idea Award: Healthcare Grant. These grants provide in-kind manufacturing services to the support development of medical products to spur innovation in the field. MedStar Health’s gravity-feed syringe holder simplifies the feeding of newborns… […]
  • Nihon Kohden launches new patient monitor
    Nihon Kohden (TYO:6849) announced the U.S. launch of its Life Scope SVM-7200 series vital signs monitor for outpatient facilities and beds that aren’t continuously monitored. The Life Scope SVM-7200 is designed to provide customizable early warning scoring to help clinicians identify patients who are deteriorating or at risk of deterioration. It combines vital signs data with… […]
  • Senate confirms Dr. Stephen Hahn to lead FDA
    The U.S. Senate has confirmed Dr. Stephen Hahn as the next commissioner of the FDA. The vote was 72 to 18, according to a report in the New York Times. Hahn will be the first permanent commissioner of the agency since Dr. Scott Gottlieb resigned in April. President Trump nominated Hahn, the chief medical officer at Houston’s… […]
  • 3M to sell drug-delivery biz to Altaris Capital Partners for $650m
    3M (NYSE:MMM) announced today that it entered into an agreement to sell most of its drug-delivery business to an affiliate of Altaris Capital Partners for approximately $650 million. St. Paul, Minn.-based 3M will retain its transdermal drug delivery components business, according to a news release. The business being divested has annual global sales reaching approximately… […]
  • Lawsuit endangers Sterigenics consent order in Georgia
    A consent order that Sterigenics entered into with the state of Georgia to reduce ethylene oxide (EtO) emissions at its Atlanta medtech sterilization plant may be in jeopardy. A hearing is scheduled today on a lawsuit that accuses the Georgia Environmental Protection Division (EPD) of failing to take public comment before entering the Aug. 7… […]
  • Trelleborg acquires Tritec Seal
    Trelleborg Sealing Solutions said today it has closed on its acquisition of rotary seal manufacturer Tritec Seal, which produces engineered polytetrafluoroethylene (PTFE) sealing solutions. Trelleborg said the acquisition strengthens its product portfolio while giving the business area access to increased manufacturing capacity. Headquartered in Fenton, Mich., with additional manufacturing in Giddings, Texas, Tritec Seal generated… […]
  • RSNA 2019: 7 radiology innovations you need to know
    Nearly 53,000 people attended the 2019 Radiological Society of North America annual meeting in Chicago last week. And they heard the same acronym over and over again: AI. Exhibitors at the conference touted their artificial-intelligence-enhanced technology at every turn, claiming to make images clearer, sharper, easier to use and powerful enough to help clinicians make… […]

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS